Total
0
Shares
Source: Therma Bright
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Therma Bright (THRM) has launched the first of three new eCommerce sites for the 2021 holiday season
  • The site will feature the Benepod, a small hand-held, hot/cold contrast therapy device for relief of chronic pain and muscle soreness
  • In the coming weeks, the company plans to launch two more eCommerce sites
  • Therma Bright is a medical technology company that develops innovative solutions that address some of today’s most important medical and healthcare challenges
  • Therma Bright Inc. (THRM) opened trading at $0.37 per share

Therma Bright (THRM) has launched the first of three new eCommerce sites for the 2021 holiday season.

The site will feature the Benepod, a small hand-held, hot/cold contrast therapy device for the relief of chronic pain and muscle soreness.

The device was specifically designed for people seeking relief from chronic pain, including Osteoarthritis of the hands, lower back pain, chronic tendonitis conditions, chronic musculoskeletal pain, neuropathic pain, plantar fasciitis, migraines and headaches, sciatica, carpal tunnel, and fibromyalgia.

“The Benepod is a great holiday gift for yourself, a family member or friend. If you seek relief from chronic pain, Benepod delivers,” remarked Therma Bright CEO Rob Fia.

In the coming weeks, the company plans to launch two more eCommerce sites featuring the Venowave and InterceptCS.

The Venowave is a Deep Vein Thrombosis medical device that utilizes wave motion massage to prevent blood clots. InterceptCS is a device that prevents cold sores before they appear.

Therma Bright’s innovative solutions, including the Benepod, Venowave, and InterceptCS, address some of today’s most important medical and healthcare challenges.

Its breakthrough proprietary technology delivered effective, non-invasive, and pain-free skincare.

The medical technology company developed the AcuVid™ COVID-19 Rapid Antigen Saliva Test, a smart-enabled medical device.

Earlier this month, the company announced that it has received conditional approval from the United States Institutional Review Board to begin a clinical performance study of the AcuVid™ test.

Therma Bright Inc. (THRM) opened trading at $0.37 per share.

More From The Market Herald
Pluribus Technologies - CEO, Richard Adair.

" Pluribus Technologies completes equity financing

Pluribus Technologies has completed a C$25M equity financing.
The Market Herald Video

" LUXXFOLIO Holdings (CSE:LUXX) provides operational update

LUXXFOLIO Holdings’ (LUXX) November updates includes record mining revenues of approximately $1.8 million and monthly rewards of 23.5 Bitcoin.
Victory Square Technologies - CEO, Shafin Diamond Tejani

" Victory Square Technologies (CSE:VST) to issue the second tranche of dividend

Victory Square (VST) will issue the second tranche of its special dividend of common shares of portfolio company Fantasy 360 Technologies in December

" Upco International (CSE:UPCO) announces Q3 2021 interim financial results

Upco International (UPCO) focused on growing its wholesale telecom business in the third quarter, resulting in higher revenue.